NCT00177008View on ClinicalTrials.gov

Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety

PHASE4CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

January 31, 2007

Conditions

SchizophreniaSchizoaffective DisorderSocial Anxiety Disorder

Interventions

DRUG

Aripiprazole

Trial Locations (1)

08854

Robert Wood Johnson Medical School - Psychiatry Dept., Piscataway

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

University of Medicine and Dentistry of New Jersey

OTHER